参考文献/References:
[1] Herr HW. Cutting for the stone: the ancient art of lithotomy[J]. BJU Int, 2008, 101(10): 1214-1216.
[2] Mishra S, Sabnis, Desai M. Stagorn morphometry: a new tool for clinical classification and prediction model for percutaneous nephrolithotomy monotherapy[J]. J Endourol, 2012, 26(8): 6-14.
[3] Qi S1, Li L, Liu R, et al. Impact of stone branch number on outcomes of percutaneous nephrolithotomy for treatment of staghorn calculi[J]. J Endourol, 2014, 28(2): 152-157.
[4] 周先明 ,疏仁义 ,郭荣利 ,等.急诊输尿管镜治疗输尿管结石并首次肾绞痛的疗效观察 [J/CD].中华腔镜泌尿外科杂志 :电子版, 2012, 5(6): 28-30.
[5] Vigen R, Weideman RA, Reilly RF. Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion[J]? Int Urol Nephrol, 2011, 43(3): 813-819.
[6] Belostotsky R, Seboun E, Idelson GH, et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III [J]. Am J Hum Genet, 2010, 87(3): 392-399.
[7] Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States[J]. Eur Urol 2012;62(1): 160-165.
[8] Turney BW, Reynard JM, Noble JG, et al. Trends in urological stone disease[J]. BJU Int 2012, 109(7): 1082-1087.
[9] Bader MJ, Eisner B, Porpiglia F, et al. Contemporary mangement of ureteral stones[J]. Eur Urol, 2012, 61(4): 764-772.
[10] Matlage BR, Jansen JP, Meckley LM, et al. Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized,controlled trails[J]. J Urol, 2012, 188(1): 130-137.
[11] Akman T, Sari E, Binbay M, et al. Comparison of outcomes after percutaneous nephrolithotomy of staghorn calculi in those with single and multiple accesses[J]. J Edourol, 2010, 24(6): 955-960.
[12] El-Nahas AR, Eraky I, Shokeir AA, et al. Factors affecting stone-free rate and complications of percutaneous nephrolithotomy for treatment of staghorn stone[J]. Urology, 2012, 9(6): 1236-1241.
[13] Ghani KR, Sammon JD, Bhojani N, et al. Trends in percutaneous nephrolithotomy use and outcomes in the United States[J]. J Urol, 2013, 190(2): 558-564.
[14] Armitage JN, Withington J, van der, et al. Percutaneous nephrolithotomy in England:practic and outcomes described in the Hospital Episode Statistics database [J]. BJU Int, 2014, 113 (5): 777-782.
[15] Desai M, De Lisa A, Turna B, et al. The clinical research office of the endourological society percutaneous nephrolithotomy global study:Stanghorn versus nonstaghorn stones [J]. J Endourol, 2011, 25(8):1263-1268.
[16] Shen P, Liu Y, Wang J. Nephrostomy tube-free versus nephrostomy tube for renal drainage after percutaneous nephrolithotomy: asystematic review and meta-analysis [J]. Urol Int 2012, 88 (3):298-306.
[17] Yuan H, Zheng S, Liu LR, et al. The efficacy and safety of tubelesspercutaneous nephrolithotomy: A systematic review and metaanalysis[J]. Urol Res, 2011, 39(5): 401-410.
[18] Shen P, Liu Y,Wang J. Nephrostomy tube-free versus nephrostomytube for renal renal drainage after percutaneous nephrolithotomy:a systematic review and meta-analysis [J]. Urol Int, 2012, 88(3):298-306.
[19] Perez Castro E, Osther PJ, Jinga V, et al. Differences inureteroscopic stone treatment and outcomes for distal, mid-,proximal,or multiple ureteral lacations: the clinical research officeof the endourological society ureteroscopy global study [J]. EurUrol, 2014, 66(1): 102-109.
[20] De la Rosette J, Denstedt J, Geavlete P, et al. The clinical researchoffice of the endurological society ureteroscopy global study:indications, complications, and outcomes in 11, 885 patients [J]. JEndourol, 2014, 28(2): 131-139.
[21] Bader MJ, Eisner B, Porpiglia F, et al. Contemporay managementof ureteral stones[J]. Eur Urol, 2012, 61(4): 764-772.
[22] Matlaga BR, Jansen JP, Meckley LM, et al. Treatment of ureteraland renal stones: a systematic review and meta-analysis of randomized, controlled trials[J]. J Urol, 2012, 188(1): 130-137.
[23] Yu W, Cheng F, Zhang X, et al. Retrograde ureteroscopic treatmentfor upper ureteral stones: a 5-year retrospective study [J]. J